Correction to “HSD17B7 Counters Bone Loss in Estrogen Deficiency via Estrogen Receptor Stabilization and Mediates the Effect of Raloxifene”

Key Points

• The correction aims to clarify the previously published findings regarding HSD17B7's mechanism in bone health.
• Correction of previously published data using DOI: 10.1002/mco2.70623
• Provides clarity on HSD17B7's role in stabilizing estrogen receptors.
• Reviews the implications of HSD17B7 in relation to raloxifene for bone loss treatment.